TRPV4 ION Channel Is Associated with Scleroderma

Journal of Investigative Dermatology

Volumn 137, Issue 4, 2017, Pages 962-965

  Goswami, Rishov ^a   Cohen, Jonathan ^a   Sharma, Shweta ^a   Zhang, David X ^b   Lafyatis, Robert ^c   Bhawan, Jag ^d   Rahaman, Shaik O ^a  

^a UNIVERSITY OF MARYLAND   (United States)

^b MEDICAL COLLEGE OF WISCONSIN   (United States)

^c UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^d BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; BLEOMYCIN; ION CHANNEL; VANILLOID RECEPTOR 4; TRPV4 PROTEIN, MOUSE; VANILLOID RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; GENE OVEREXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOBLOTTING; IMMUNOFLUORESCENCE TEST; MOUSE; MYOFIBROBLAST; NONHUMAN; PROTEIN LOCALIZATION; SCLERODERMA; SKIN BIOPSY; SKIN FIBROSIS; ANIMAL; C57BL MOUSE; DISEASE MODEL; FIBROSIS; KNOCKOUT MOUSE; PATHOLOGY; PHYSIOLOGY; SKIN; SYSTEMIC SCLEROSIS;

ANIMALS; DISEASE MODELS, ANIMAL; FIBROSIS; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; SCLERODERMA, SYSTEMIC; SKIN; TRPV CATION CHANNELS;

EID: 85015888580     PISSN: 0022202X     EISSN: 15231747     Source Type: Journal    
DOI: 10.1016/j.jid.2016.10.045     Document Type: Article

References (15)

1. Castelino, F.V., Varga, J., Emerging cellular and molecular targets in fibrosis: implications for scleroderma pathogenesis and targeted therapy. Curr Opin Rheumatol 26 (2014), 607–614.
2. Everaerts, W., Nilius, B., Owsianik, G., The vanilloid transient receptor potential channel TRPV4: from structure to disease. Prog Biophys Mol Biol 103 (2010), 2–17.
3. Garcia-Elias, A., Mrkonjić, S., Jung, C., Pardo-Pastor, C., Vicente, R., Valverde, M.A., The TRPV4 channel. Handb Exp Pharmacol 222 (2014), 293–319.
4. Hinz, B., Tissue stiffness, latent TGF-beta1 activation, and mechanical signal transduction: implications for the pathogenesis and treatment of fibrosis. Curr Rheumatol Rep 11 (2009), 120–126.
5. Ho, Y.Y., Lagares, D., Tager, A.M., Kapoor, M., Fibrosis—a lethal component of systemic sclerosis. Nat Rev Rheumatol 10 (2014), 390–402.
6. Rahaman, S.O., Grove, L.M., Paruchuri, S., Southern, B.D., Abraham, S., Niese, K.A., et al. TRPV4 mediates myofibroblast differentiation and pulmonary fibrosis in mice. J Clin Invest 124 (2014), 5225–5238.
7. Rajkumar, V.S., Howell, K., Csiszar, K., Denton, C.P., Black, C.M., Abraham, D.J., Shared expression of phenotypic markers in systemic sclerosis indicates a convergence of pericytes and fibroblasts to a myofibroblast lineage in fibrosis. Arthritis Res Ther 7 (2005), R1113–R1123.
8. Rubio-Rivas, M., Royo, C., Simeón, C.P., Corbella, X., Fonollosa, V., Mortality and survival in systemic sclerosis: systematic review and meta-analysis. Semin Arthritis Rheum 44 (2014), 208–219.
9. Sokabe, T., Tominaga, M., The TRPV4 cation channel: a molecule linking skin temperature and barrier function. Commun Integr Biol 3 (2010), 619–621.
10. Suzuki, M., Mizuno, A., Kodaira, K., Imai, M., Impaired pressure sensation in mice lacking TRPV4. J Biol Chem 278 (2003), 22664–22668.
11. Tanjore, H., Xu, X.C., Polosukhin, V.V., Degryse, A.L., Li, B., Han, W., et al. Contribution of epithelial-derived fibroblasts to bleomycin-induced lung fibrosis. Am J Respir Crit Care Med 180 (2009), 657–665.
12. Tschumperlin, D.J., Fibroblasts and the ground they walk on. Physiology (Bethesda) 28 (2013), 380–390.
13. Webster, K.D., Ng, W.P., Fletcher, D.A., Tensional homeostasis in single fibroblasts. Biophys J 107 (2014), 146–155.
14. Wong, V.W., Longaker, M.T., Gurtner, G.C., Soft tissue mechanotransduction in wound healing and fibrosis. Semin Cell Dev Biol 23 (2012), 981–986.
15. Yamamoto, T., Takagawa, S., Katayama, I., Yamazaki, K., Hamazaki, Y., Shinkai, H., et al. Animal model of sclerotic skin. I: local injections of bleomycin induce sclerotic skin mimicking scleroderma. J Invest Dermatol 112 (1999), 456–462.